-
-
-
-
-
-
-
Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results
-
-
-
-
-
-
-
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
-
-
-
-
-
-
-
Endo Announces Seven New Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting
-
-
-
-
-
-
-
Endo Files Registration Statement with SEC, Advancing Planned Move to NYSE
67,640 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

